RYMNasdaqAgricultural ServicesUS GAAP · USD

RYTHM, Inc.

RYTHM, Inc. is a U.S.-based consumer products company focused on hemp-derived THC beverages, edibles, and other branded cannabinoid products. Through its subsidiaries, it also licenses intellectual property and brand rights to third parties, with a portfolio that includes RYTHM, incredibles, Dogwalkers, Beboe, &Shine, Doctor Solomon’s, Good Green, and Señorita.

Kysy yhtiöstä
Liikevaihto17,3milj. USD
+78,5 %v/v
Liikevoitto (EBIT)−32,3milj. USD
−216,6 %v/v
EBIT-marginaali−187,1%
−81,6 %-yks.v/v
Nettotulos−33,3milj. USD
+20,3 %v/v
Vapaa kassavirta−23,5milj. USD
−103,2 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2020–2025

−200−1000100milj. USD2020: 12 milj. USD2020: EBIT −13 milj. USD20202021: 60 milj. USD2021: EBIT −35 milj. USD20212022: 58 milj. USD2022: EBIT −193 milj. USD20222023: 15 milj. USD2023: EBIT −13 milj. USD20232024: 9,7 milj. USD2024: EBIT −10 milj. USD20242025: 17 milj. USD2025: EBIT −32 milj. USD202517−32
LiikevaihtoLiikevoitto (EBIT)
Kysy Clarifolta: RYTHM, Inc.

Liiketoiminta

Osuus liikevaihdosta
Hemp-derived THC beverages45 %

Ready-to-drink hemp THC beverages sold under the Señorita and RYTHM brands.

Hemp-derived edibles35 %

Edible cannabinoid products including gummies and related formats under brands such as incredibles and Beboe.

Licensed consumer brands20 %

Brand rights licensed to third parties for manufacturing and distribution in exchange for fees.

Tuotteet

Raportoitu · osuus liikevaihdosta
55,0%45,0%FY2025100 %
  • Nonlicensing Revenue55,0 %
  • License45,0 %

Lähde: 10-K FY2025, yhtiön tuotelinjoittain raportoima liikevaihto (SEC XBRL). Osuudet on laskettu näytetyistä riveistä ja ne summautuvat 100 %:iin.

Asiakkaat

RYTHM sells to consumers seeking hemp-derived THC alternatives to alcohol and traditional cannabis products, especially in beverage and edible formats. It also serves retail partners and distributors that carry its branded products, as well as a related-party licensee that uses its intellectual property in state-licensed cannabis operations.

Adult hemp beverage consumers

Buy Señorita and similar THC beverages as alcohol alternatives for social occasions and relaxation.

Edible cannabinoid consumers

Purchase gummies and other ingestible products for convenience, discretion, and brand preference.

Retail and distribution partners

Stock and distribute branded products because they want differentiated hemp THC offerings.

Licensing counterparties

Use the company’s brands and intellectual property in exchange for sales-based fees.

Strategia

RYTHM’s strategy centers on repositioning the business around hemp-derived THC beverages and branded consumer products while monetizing its intellectual property through licensing. It is also building distribution through retail partnerships, online channels, and selective geographic expansion where hemp products are permitted.

Build a hemp-derived beverage platformLyhyt aikaväli

Beverages are the most visible consumer-facing category and can drive repeat purchases and brand recognition.

Scale branded consumer packaged goodsKeskipitkä aikaväli

A broader portfolio improves shelf presence and reduces reliance on any single product format.

Monetize intellectual property through licensingKeskipitkä aikaväli

Licensing can extend brand reach without requiring full manufacturing and distribution ownership.

Maantiede

RYTHM is headquartered in the United States and sells primarily in U.S. states where hemp-derived THC products are permitted. The company also sells Señorita in Canada and has described expansion into additional retail and on-premises channels, making regulatory access a key part of its geographic footprint.

Riskit

RYTHM is exposed to regulatory risk because hemp-derived THC products depend on federal, state, and local rules that can change or tighten. The business also faces concentration risk in a narrow product set and limited geographies, plus execution risk around product acceptance, retailer adoption, licensing relationships, and access to financing.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Federal or state restrictions on hemp-derived THC products1Geographic concentration2Financing and liquidity access3Customer licensing and regulatory compliance risk4Product acceptance and competition5
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Federal or state restrictions on hemp-derived THC productsVaikutus: KorkeaTodennäköisyys: Kohtalainen

    The company’s core products depend on the legal status of hemp THC and related enforcement interpretations.

    Kohdistuu: Hemp-derived THC beverages and edibles

  2. Geographic concentrationVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Sales are limited to jurisdictions that permit hemp-derived THC products, increasing regulatory and market concentration.

    Kohdistuu: U.S. states and Canada

  3. Financing and liquidity accessVaikutus: KorkeaTodennäköisyys: Kohtalainen

    The business may need external capital to support working capital and growth, and funding terms may be unfavorable.

    Kohdistuu: Working capital and inventory support

  4. Customer licensing and regulatory compliance riskVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Some customers must maintain licenses to operate, and loss of those licenses can reduce sales and licensing revenue.

    Kohdistuu: Retail and licensed cannabis counterparties

  5. Product acceptance and competitionVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Branded hemp products compete with alcohol, cannabis, and other consumer packaged goods offerings.

    Kohdistuu: New beverage and edible launches

Kysy Clarifolta: RYTHM, Inc.

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition for product sales and licensing fees

The company has both physical product revenue and sales-based license revenue, which may be recognized at different times.

Vaikutus: Affects reported revenue mix and quarter-to-quarter comparability

Fair value of warrant liabilities and derivatives

The company reports changes in fair value for warrants and related instruments, which can materially affect non-operating results.

Vaikutus: Can create large non-cash swings in earnings

Goodwill impairment

Goodwill is subject to annual and interim impairment testing based on projected performance and market value.

Vaikutus: Potential for material write-downs if expectations weaken

Business combinations and asset acquisitions

Recent acquisitions require purchase accounting and valuation of acquired brands and assets.

Vaikutus: Influences intangible assets, amortization, and future impairment risk

Samankaltaisia listattuja yhtiöitä

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Rhythm Pharmaceuticals, Inc

RYTM · Pharmaceutical Preparations

Rithm Property Trust Inc.

RPT-PC · Real Estate Investment Trusts

cbdMD, Inc.

YCBD · Perfumes, Cosmetics & Other Toilet Preparations

Charlotte's Web Holdings, Inc.

CWBHF · Agricultural Production-Crops

Rithm Acquisition Corp.

RAC-WT · Blank Checks

Green Thumb Industries Inc.

GTBIF · Agricultural Production-Crops

Päivitetty: 24.9.2026

RYTHM, Inc. (Nasdaq) – Agricultural Services | Analyysi – Clarifo